Start / BioCentury This Week

BioCentury This Week

320 avsnitt • Längd: 25 min • Veckovis: Tisdag

Life Science • Näringsliv • Vetenskap

BioCentury’s streaming commentary on biotech industry trends, plus interviews with KOLs.For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.

Avsnitt

Ep. 310 - Sarepta & What's Next for Gene Therapy. Plus: Leading FDA's CDER

22 juli | 32 min

Ep. 309 - 3Q Markets Preview; Quantum Computing; Makary’s First 100 Days

14 juli | 37 min

Ep. 308 - Grand Rounds - Europe Preview

9 juli | 31 min

Ep. 307 - How Cancer Regulation is — and isn’t — Changing at FDA

8 juli | 30 min

Ep. 306 - Treg Inflection Point; Biotech's Next Big Story; Tax Bill Consequences

8 juli | 32 min

Ep. 305 - FDA's Future; In Vivo CAR T Plays; Psychedelics; CDK2

1 juli | 39 min

Ep. 304 - Syncona Reshapes Fund; Lilly's $1B Verve Bet; FDA's 2-Track Future

24 juni | 35 min

Ep. 303 - Gene Therapy Safety, Amylin in Obesity & FDA's Future

16 juni | 34 min

Ep. 302 - Takeaways from BioCentury Grand Rounds Chicago

12 juni | 31 min

Ep. 301 - ASCO’s First-in-Human Trials, Crossover Investors & FDA's Rare Disease Plans

10 juni | 36 min

Ep. 300 - Biotech’s $13B Deal Day, ASCO's Hot Targets, Drug Pricing Threat

3 juni | 39 min

Ep. 299 - ASCO, EpCAM, Rocket & HK IPOs

28 maj | 31 min

Ep. 298 - Takeaways from the 25th Bio€quity Europe

23 maj | 39 min

Ep. 297 - European Biotech's Moment? Plus: Biomarin, Boston Deals & Novo Nordisk CEO

20 maj | 36 min

Ep. 296 - Trends in Obesity, Vinay Prasad at FDA, Ovarian Cancer Insights

13 maj | 33 min

Podden BioCentury This Week är skapad av BioCentury. Poddens innehåll och bilderna på den här webbplatsen hämtas med hjälp av poddens RSS-flöde.

Podcastbild

00:00 -00:00

Podcastbild

00:00 -00:00